These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus. Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775 [TBL] [Abstract][Full Text] [Related]
23. Mouse Models for the Study of SARS-CoV-2 Infection. Knight AC; Montgomery SA; Fletcher CA; Baxter VK Comp Med; 2021 Oct; 71(5):383-397. PubMed ID: 34610856 [TBL] [Abstract][Full Text] [Related]
24. SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study. Schlottau K; Rissmann M; Graaf A; Schön J; Sehl J; Wylezich C; Höper D; Mettenleiter TC; Balkema-Buschmann A; Harder T; Grund C; Hoffmann D; Breithaupt A; Beer M Lancet Microbe; 2020 Sep; 1(5):e218-e225. PubMed ID: 32838346 [TBL] [Abstract][Full Text] [Related]
25. SARS CoV-2 infections in animals, two years into the pandemic. Frazzini S; Amadori M; Turin L; Riva F Arch Virol; 2022 Dec; 167(12):2503-2517. PubMed ID: 36207554 [TBL] [Abstract][Full Text] [Related]
26. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2. Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750 [TBL] [Abstract][Full Text] [Related]
27. Animal reservoirs of SARS-CoV-2: calculable COVID-19 risk for older adults from animal to human transmission. Valencak TG; Csiszar A; Szalai G; Podlutsky A; Tarantini S; Fazekas-Pongor V; Papp M; Ungvari Z Geroscience; 2021 Oct; 43(5):2305-2320. PubMed ID: 34460063 [TBL] [Abstract][Full Text] [Related]
28. Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2. Chakravarty D; Das Sarma J J Neurovirol; 2021 Apr; 27(2):197-216. PubMed ID: 33547593 [TBL] [Abstract][Full Text] [Related]
29. Early protective effect of a ("pan") coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration. Abdelaziz MO; Raftery MJ; Weihs J; Bielawski O; Edel R; Köppke J; Vladimirova D; Adler JM; Firsching T; Voß A; Gruber AD; Hummel LV; Fernandez Munoz I; Müller-Marquardt F; Willimsky G; Elleboudy NS; Trimpert J; Schönrich G Front Immunol; 2023; 14():1166765. PubMed ID: 37520530 [TBL] [Abstract][Full Text] [Related]
30. Characteristics of animal models for COVID-19. Qi F; Qin C Animal Model Exp Med; 2022 Oct; 5(5):401-409. PubMed ID: 36301011 [TBL] [Abstract][Full Text] [Related]
31. An Update on Animal Models for Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Countermeasure Development. Zhang L; Chen S; Zhang W; Yang H; Jin Y; Duan G Front Microbiol; 2021; 12():770935. PubMed ID: 34819926 [TBL] [Abstract][Full Text] [Related]
32. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. Li K; Meyerholz DK; Bartlett JA; McCray PB mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553 [TBL] [Abstract][Full Text] [Related]
33. Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models. Kim YI; Casel MAB; Choi YK J Microbiol; 2022 Mar; 60(3):255-267. PubMed ID: 35235177 [TBL] [Abstract][Full Text] [Related]
35. Animal Models for the Study of Neurologic Manifestations Of COVID-19. Carpenter KC; Yang J; Xu JJ Comp Med; 2023 Feb; 73(1):91-103. PubMed ID: 36744556 [TBL] [Abstract][Full Text] [Related]
36. SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats. Tamil Selvan M; Gunasekara S; Xiao P; Griffin K; Cowan SR; Narayanan S; Ramachandran A; Hagen DE; Ritchey JW; Rudd JM; Miller CA Viruses; 2022 Jun; 14(6):. PubMed ID: 35746678 [TBL] [Abstract][Full Text] [Related]
37. A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice. Liu MQ; Lin HF; Li J; Chen Y; Luo Y; Zhang W; Hu B; Tian FJ; Hu YJ; Liu YJ; Jiang RD; Gong QC; Li A; Guo ZS; Li B; Yang XL; Tong YG; Shi ZL J Virol; 2023 Feb; 97(2):e0171922. PubMed ID: 36688655 [TBL] [Abstract][Full Text] [Related]
38. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
39. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
40. Bats, pangolins, minks and other animals - villains or victims of SARS-CoV-2? do Vale B; Lopes AP; Fontes MDC; Silvestre M; Cardoso L; Coelho AC Vet Res Commun; 2021 Feb; 45(1):1-19. PubMed ID: 33464439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]